Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |Streptavidin（SA） Hot |Claudin 18.2 |Cadherin-17 
0
There is no goods in the shopping cart !
My Cart|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > FKBP12

FKBP12

Brief Information

Name:FK506-binding protein 1A
Target Synonym:Peptidyl-Prolyl Cis-Trans Isomerase FKBP1A,FK506-Binding Protein, T-Cell, 12-KD,FK506-Binding Protein 1A (12kD),Protein Kinase C Inhibitor 2,FK506-Binding Protein 12,FK506 Binding Protein12,FK506-Binding Protein 1,FKBP12-Exip3,Calstabin 1,PPIASE,PKC12,PKCI2,Tacrolimus Binding Protein 1A,FKBP12C,FK506 Binding Protein 1A, 12kDa,12 KDa FK506-Binding Protein,Immunophilin FKBP12,12 KDa FKBP,Rotamase,FKBP Prolyl Isomerase 1A,FKBP1,FKBP12,FKBP-12,PPIase FKBP1A,FK506-binding protein 1A,Calstabin-1,FKBP-
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
FKA-H5122 Human Human FKBP12 / FKBP1A Protein, His Tag
FKA-H5122-structure
FKA-H5122-sds
ACRO Quality

Synonym Name

FKBP1A,FKBP1,Calstabin-1,FKBP12,Rotamase,PKC12,PPIASE

Background

Peptidyl-prolyl cis-trans isomerase FKBP1A, a member of the FKBP-type PPIase family and FKBP1 subfamily, is also known as FK506-binding protein 1A, immunophilin FKBP12 and 12 kDa FK506-binding protein, which contains one PPIase FKBP-type domain. FKBP1A is a cis-trans prolyl isomerase that binds the immunosuppressants FK506 (tacrolimus) and rapamycin (sirolimus).FKBP1A interacts with several intracellular signal transduction proteins including type I TGF-beta receptor. FKBP1A can also interact with multiple intracellular calcium release channels including the tetrameric skeletal muscle ryanodine receptor. Furthermore, FKBP1A can recruite SMAD7 to ACVR1B which prevents the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tacrolimus Hydrate FR-900506; L-679934; FK-506MR; FK-506E; FK-506; MR-4; RTU-007; LCP-Tacro Approved Astellas Pharma Inc Protopy, Graceptor (as hydrate), Protopic, Prograf (as hydrate), Hecoria (as hydrate), Hexal, Envarsus XR, Talymus, 普乐可复, Advagraf, Envarsus, Modigraf, Astagraf XL, TacroBell Japan Arthritis, Rheumatoid; Colitis, Ulcerative; Conjunctivitis, Allergic; Lupus Nephritis; Coronary Restenosis; Dermatitis, Atopic; Rejection of organ transplantation; Myasthenia Gravis Astellas Pharma Inc 1993-01-01 Wounds and Injuries; Rejection of organ transplantation; Lupus Nephritis; Brain Death; Psoriasis; Amputation, Traumatic; Conjunctivitis, Allergic; Colitis, Ulcerative; Asthma; Surgical Wound Infection; Keratoconjunctivitis; Rejection in heart transplantation; Lung Diseases, Interstitial; Infertility, Female; Nephrotic Syndrome; Renal Insufficiency, Chronic; Coronary Restenosis; Ocular inflammation; Dermatitis, Atopic; Encephalitis; Edema; Peripheral Nerve Injuries; Vitiligo; Crohn Disease; Rejection of lung transplantation; Keratoconjunctivitis Sicca; Rejection of renal transplantation; Polymyositis; Bone marrow transplant rejection; Liver Failure; Genital Diseases, Male; Reperfusion Injury; Medication Adherence; Rejection of liver transplantation; Glomerulonephritis, IGA; Dermatomyositis; Myasthenia Gravis; Primary Graft Dysfunction; Renal Insufficiency; Keratoplasty rejection; Cystitis; Kidney Diseases; Lupus Erythematosus, Cutaneous; Arthritis, Rheumatoid; Graft vs Host Disease; Conjunctivitis; Dry Eye Sy Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Rimiducid AP-1903 Phase 1 Clinical Ariad Pharmaceuticals Inc Hematologic Neoplasms; Multiple Myeloma; Sarcoma; Neuroblastoma; Osteosarcoma; Melanoma Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap